Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application

The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application

Author
Recent Posts

GlobeNewswire

GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Related Posts

Kronos Advanced Technologies Announces Cyber Monday Savings of Up to 50% on Innovative Air Purification Products, Plus Exclusive Deals Throughout the Holiday Season

AIFXL’s Disruptive AI Technology Redefines Forex Trading Amid Industry Scrutiny

Notice of Delisting and Re-Compliance of Nasdaq Listing Rule

Mulvihill Capital Management Inc. Announces Approval of Proposal for Mulvihill U.S. Health Care Enhanced Yield ETF, Name Change to Mulvihill Enhanced Split Preferred Share ETF And Consolidation Ratio

Stallion Uranium Announces Conditional Acceptance of the TSX Venture Exchange of Definitive Option Agreement for Horse Heaven Gold and Antimony Project

Brookfield Infrastructure Renews Its Normal Course Issuer Bids

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Latest Posts

Welcome Back!

Retrieve your password